The World Health Organisation (WHO) reports that corneal blindness affects more than 10 million people worldwide, however only 100,000 people receive corneal transplants each year. This shortfall is due to a combination of inadequate supply of donor corneas and the unsuitability of some patients to receive a corneal graft.
AlphaCor is designed for use in patients who have had multiple failed corneal transplants or in those patients in whom a donor graft is likely to fail.
Its patented design features are aimed to promote retention, minimize post-operative complications and restore vision in patients who cannot receive, or are unlikely to have a beneficial outcome from, a human donor graft.
AlphaCor is available in two versions, to suit those with a natural lens (phakic) or artificial lens (pseudophakic) and for those without a lens (aphakic).
Get quote from Addition Technology, Inc. for AlphaCor™ Artificial Cornea